SCOPE 2018

Medrio expanding globally following $30m investment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/KenTannenbaum)
(Image: Getty/KenTannenbaum)
The healthcare technology company Medrio is expanding its business both internationally and domestically following a $30m investment – and demand knocking on its door.

Last year Medrio closed a $30m equity investment from Questa Capital Management, a venture capital firm. The investment was the first of its kind for the company’s twelve-year history, according to Medrio.

We’ve seen a lot of demand both in Europe and Asia​,” Leslie Olsen, vice president of product marketing at Medrio told us at the SCOPE Summit earlier this month.

Speaking at the company’s booth during SCOPE, Olsen said she was hearing a lot of the same things she usually hears at such events. Mainly, “We need tools that will easily integrate with what we’re doing. That don’t require a ton of training​.”

People who are looking to be more nimble – to fail fast, to make a decision quickly … we help them do that​,” she said.

Most recently, the company announced that Linear Clinical Research, an Australia-based Phase I unit, has implemented Medrio’s technology – a move that marked the company's first departure from paper-based data capture.

“[Liner Clinical Research] helped us understand that we have a real footprint there [in Asia]​,” said Olsen.

For us we’re really just trying to capitalize on the demand that’s coming to us, just knocking on our door​,” she added.

To meet this increasing demand, Medrio is opening offices in Charlotte, NC Heidelberg, Germany, and Tokyo, Japan, and is also increasing its business development headcount.

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars